Activity of GH/IGF-I axis in patients with dilated cardiomyopathy

Clinical Endocrinology

Volumn 50, Issue 4, 1999, Pages 417-430

  Broglio, Fabio ^c   Fubinl, Alberto ^c   Morello, Mara ^c   Arvat, Emanuela ^c   Aimaretti, Gianluca ^c   Gianotti, Laura ^c   Boghen, Muny F ^c   Deghenghi, Romano ^a   Mangiardi, Lucla ^c   Ghigo, Ezio ^b  

^a Ardana   (France)

^b MOLINETTE HOSPITAL   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RELEASING FACTOR[1-29]; HEXARELIN; HUMAN GROWTH HORMONE; SERMORELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLUSHING; HEART DILATATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OLIGOPEPTIDES;

EID: 0005627046     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00696.x     Document Type: Article

References (78)

1. Albertsson-Wikland, K. & Rosberg, S. (1988) Analyses of 24-hour Growth Hormone profiles in children: relation to growth. Journal of Clinical Endocrinology and Metabolism, 67, 493-500.
2. Amato, G., Carella, C., Fazio, S., La Montagna, G., Cittadini, A., Sabatini, D., Marciano-Mone, C., Saccà, L. & Bellastella, A. (1993) Body composition, bone metabolism and heart structure and function in Growth Hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism, 77, 1671-1676.
3. Anker, S.D., Ponikowski, P., Varney, S., Chua, T.P., Clark, A.L., Webb-Peploe, K.M., Harrington, D., Kox, W.J., Poole-Wilson, P.A. & Coats, A.J.S. (1997) Wasting as independent risk factor for mortality in chronic heart failure, Lancet. 349, 1050-1053.
4. Arvat, E., Bellone, J., Procopio, M., Grottoli, S., Maccario, M., Camanni, F. & Ghigo, E. (1996) Neuroregulation of Growth Hormone secretion in man. Developmental Brain Dysfunction, 9, 93-99.
5. Baumann, G. (1991) Growth hormone heterogeneity: genes, isohormones, variants and binding proteins. Endocrine Review, 12, 424-449.
6. Bertoni, P.D. & Morandi, G. (1985) Impaired left ventricular diastolic function in acromegaly: an echocardiographic study. Acta Cardilogica,42, 1-10..
7. Blum, W.F., Albertsson-Wikland, K., Rosberg, S. & Ranke, M.B. (1993) Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. Journal of Clinical Endocrinology and Metabolism, 76, 1610-1616.
8. Blum, W.F., Cotterill, A.M., Postel-Vinay, M.C., Ranke, M.B., Savage, M.O. & Wilton, P. (1994) Improvement of diagnostic criteria in growlh hormone insensitivity syndrome: solution and pitfalls. Acta Pediatrica, suppl. 339, 117-124.
9. Blum, W.F., Ranke, M.B., Savage, M.O. and the Kabi Pharmacia study group on IGF-I treatment in GHIS. (1992) Insulin-like growth factor and their binding proteins in patients with growth hormone receptors deficiency: suggestion for new diagnostic criteria. Acta Pediatrica, suppl. 383, 125-124.
10. Bowers, C.Y. (1993) GH releasing peptides. Structures and kinetics. Journal of Pediatrics and Endocrinology, 6, 21-31.
11. Bowers, C.Y., Sartor, A.O., Reynolds, G.A. & Badger, T.M. (1991) On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology, 128, 2027-2035.
12. Brink, M., Wellen, J. & Delafontaine, P. (1996) Angiotensin II causes weight loss and decreases circulating insulin-like growlh factor-I in rats through a pressor-independent mechanism. Journal of Clinical Investigation, 97, 2509-2516.
13. Casati, M., Poggesi, I., Aimaretti, G., Pellizzone, S., James, C. & Miola, A. (1997) Bioanalytical validation of high affinity GH-binding protein (GHBP-2) assay and GHBP-2 levels in normal and in pathophysiological conditions. Journal of Endocrinological Investigation, 20 (S4), 16.
14. Cittadini, A., Stromer, H., Katz, S.E., Clark, R., Moses, A., Morgan, J. & Douglas, P. (1996) Differential cardiac effects of growth hormone and insulin-like growth factor I in the rat. A combined in vivo and in vitro evaluation. Circulation, 93, 800-809.
15. Clemmons, D.R., Seck, M. & Underwood, L.E. (1985) Supplementary essential amino acids augment the somatomedin-C/insulin-like growth factor-I response to refeeding after fasting. Metabolism, 34, 391-395.
16. Cotterill, A.M., Camacho-Hubner, C., Woods, K., Martinelli, C., Duquesnoy, P. & Savage, M.O. (1994) The insulin-like growth factor generation test in the investigation of short stature. Acta Pediatrica, suppl. 339, 128-130.
17. Cuneo, R.C., Salomon, F., Wiles, C.M., Hesp, R. & Sonksen, P.H. (1991a) Growth hormone treatment in growth hormone deficient adults. I. Effects on muscle mass and strength. Journal of Applied Physiology, 70, 688-694.
18. Cuneo, R.C., Salomon, F., Wiles, C.M., Hesp, R. & Sonksen, P.H. (1991b) Growth hormone treatment in growth hormone deficient adults. 1. Effects on exercise performance. Journal of Applied Physiology, 70, 695-700..
19. De Boer, H., Blok, J., Popp-Snijders, C., Stuurman, L., Baxter, R.C. & Van der Veen, E. (1996) Monitoring of growth hormone replacement therapy in adults, based on measurement of serum marker. Journal of Clinical Endocrinology and Metabolism, 81, 1371-1376.
20. Diez, J. & Laviades, C. (1994) Insulin-like growth factor-I and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. Journal of Hypertension, 12 (4), S31-36.
21. Donath, M.Y., Zapf, J., Eppenberger-Eberhardt, M., Froesch, E.R. & Eppenberger, H.M. (1994) Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle α-actin of adult cardiomyocytes. Proceedings of the National Academy of Science of the U.S.A., 91, 1686-1690.
22. Duerr, R.L., Huang, S., Miraliakbar, H.R., Clark, R., Chien, K.R. & Ross, J. (1995) Insulin-Like Growth Factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. Journal of Clinical Investigation, 95, 619-627.
23. Engelmann, G.L., Boehm, K.D., Haskell, J.F., Khairallah, P.A. & Ilan, J. (1989) Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats. Molecular and Cellular Endocrinology, 63, 1-14.
24. Fazio, S., Cittadini, A., Sabatini, D., Merola, B., Colao, A.M., Biondi, B., Lombardi, G. & Saccà, L. (1993) Evidence of biventricular involvement in acromegaly: a Doppler echocardiographic study. European Heart Journal, 14, 26-33.
25. Fazio, S., Cittadini, A., Cuocolo, A., Merola, B., Sabatini, D., Nicolai, H., Colao, A., Biondi, B., Lombardi, G. & Saccà, L. (1994) Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. Journal of Clinical Endocrinology and Metabolism, 79, 441-446.
26. Fazio, S., Sabatini, D., Capaldo, B., Vigorito, C., Giordano, A., Guida, R., Pardo, F., Biondi, B. & Saccà, L. (1996a) A preliminary Growth Hormone in the treatment of dilated cardiomyopathy. New England Journal of Medicine, 34, 809-814.
27. Fazio, S., Bondi, B., Sabatini, D., Cuocolo, A., Tommaselli, A.P., Lombardi, G. & Saccà, L. (1996b) Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. Journal of Clinical Endocrinology and Metabolism, 81, 887-890.
28. Ghigo, E., Arvat, E., Gianotti, L., Ramunni, J., Di Vito, L., Maceagno, B., Grottoli, S. & Camanni, F. (1996) Human aging and the GH/IGF-I axis. Journal of Pediatri Endocrinology and Metabolism, 9, 271-278.
29. Ghigo, E., Arvat, E., Muccioli, G. & Camanni, F. (1997) Growth hormone-releasing peptides. European Journal of Endocrinology, 136, 445-460.
30. Giustina, A., Lorusso, R., Borghetti, V., Bugari, G., Misitano, V. & Alfieri, O. (1996) Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. American Heart Journal, 131, 620-622.
31. Giustina, A., Volterrani, M., Desenzani, P., Lorusso, R., Manelli, F., Perini, P., Poiesi, C., Romanelli, G. & Gordano, A. (1997) Endocrine predictors of the acute hemodinamic effects of growth hormone in patients with severe heart failure. 79th Annual Meeting The Endocrine Society, Minneapolis, 1997, p. 93.
32. Goth, M.I., Lyons, C.E., Canny, B.Y. & Thorner, M.O. (1992) Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology, 130, 939-944.
33. Gourmelen, M., Girard, F. & Binoux, M. (1982) Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing syndrome or receiving glucocorticoid therapy. Journal of Clinical Endocrinology and Metabolism, 54, 885-892.
34. Guse, A.H., Kiess, W., Funk, B., Kessler, U., Berg, I. & Gercken, G. (1992) Identification and characterization of insulin-like growth factor receptors on adult rat cardiac myocytes: linkage to inositol 1,4,5-trisphosphate formation. Endocrinology, 130, 145-151.
35. Hatle, L. & Angelsen, B. (1985) Doppler ultrasound in cardiology (eds. L. Hatle & B. Angelsen), Lea and Febiger, Philadelphia.
36. Hirsch, E.Z., Sloman, J.G. & Martin, F.I. (1969) Cardiac function in acromegaly. American Journal of Medicine, 57, 823-829.
37. Ho, K.Y., Evans, W.S., Blizzard, R.M., Veldhuis, J.D., Merriam, G.R., Samojlik, e., Furlanetto, R., Rogol, A.D., Kaiser, D.L. & Thorner, M.O. (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism, 64, 51-58.
38. Isgaard, J., Kujacic, V., Jennische, E., Holmang, A., Sun, X.Y., Hedner, T., Hjalmarson, A. & Bengtsson, B.A. (1997) Growth hormone improves cardiac function in rats with experimental myocardial infarction. European Journal of Clinical Investigation, 27, 517-525.
39. Isgaard, J., Nilsson, A., Vilkman, K. & Isaksson, O.G.P. (1989) Growth Hormone regulates the level of Insulin-Like Growth Factor mRNA in rat skeletal muscle. Journal of Endocrinology, 120, 107-112.
40. Ito, H., Hiroe, M., Hirata, Y., Motoyoshi, T., Adachi, S., Masayoshi, S., Koike, A., Nogami, A. & Marumo, F. (1993) Insulin-Like Growth Factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation, 87, 1715-1721.
41. Johannsson, G., Bengtsson, B.A., Andersson, B., Isgaard, J. & Caidahl, K. (1996) Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clinical Endocrinology, 45, 305-314.
42. Jones, J. & Clemmons, D.R. (1995) Insulin-like growth factor and their binding proteins: biological actions. Endocrine Review, 16, 3-34.
43. Juul, A., Bang, P., Hertel, N.T., Dalgaard, P., Jorgensen, K., Muller, J., Hall, K. & Skakkerbaek, N.E. (1994) Serum insulin-like growth factor-1 in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size and body mass index. Journal of Clinical Endocrinology and Metabolism, 78, 744-753.
44. Lee, P.D.K., Wilson, D.M., Rountree, L., Hintz, R.L. & Rosenfeld, R.G. (1990) Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing. Pediatric Research, 27, 45-51.
45. Lie, J.T. & Grossman, S.J. (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients, American Heart Journal, 100,41-52.
46. Mangieri, E., Tosti-Croce, C., Tanzilli, G., Barillà, F., Nardi, M., Poggi, M., Ciavolella, M., Farinelli, A., Mangiaracina, F. & Campa, P.P. (1996) Impairment of Growth hormone/Insulin-like growth factor-I axis in normopituitaric patients with biventricular cardiac failure and hepatic stasis. Cardiologica, 41 (5), 449-453.
47. Mather, H.M., Boyd, M.J. & Jenkins, J.S. (1979) Heart size and function in acromegaly. British Heart Journal, 41, 697-701.
48. Mathews, L.S., Enberg, B. & Norstedt, G. (1989) Regulation of rat growth hormone receptors gene expression. Journal Biological Chemistrv, 17, 9905-9910.
49. Mayoux, E., Ventura-Clapier, R., Timsit, J., Béhar-Cohen, F., Hoffmann, C. & Mercadier, J.J. (1993) Mechanical properties of rat cardiac skinned fibers are altered by chronic Growth Hormone hypersecretion. Circulation Research, 72, 57-64.
50. Merola, B., Cittadini, A., Colao, A., Longobardi, S., Fazio, S., Sabatini, D., Saccà, L. & Lombardi, G. (1993) Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 77, 1658-1661.
51. Miell, J.P., Buchanan, C.R., Norman, M.R., Maheshwari, T. & Blum, W.F. (1994) The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding proteins as a result of short term dexamethasone treatment. Journal of Endocrinology, 142, 547-554.
52. Morvan, D., Komajda, M., Grimaldi, A., Turpin, G. & Grosgogeat, Y. (1991) Cardiac hypertrophy and function in asymptomatic acromegaly. European Heart Journal, 12, 666-672.
53. Niebauer, J., Pflaum, C.D., Clark, A.L., Strasburger, C.J., Hooper, J., Poole-Wilson, P.A., Coats, A.J.S. & Anker, S.D. (1998) Deficient Insulin-like Growth Factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. Journal of American College of Cardiology, 31, 393-397.
54. Osterziel, K.J., Strohm, O., Schuler, J., Friedrich, M., Hanlein, D., Willenbrock, R., Anker, S.D., Poole-Wilson, P.A., Ranke, M.B. & Dietz, R. (1998) Randomized, double bind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet, 351, 1233-1237.
55. Pflaum, C.D., Anker, S.D., Volterrani, M., Poole-Wilson, P.A., Coats, A.J.S. & Strasburger, C.J. (1997) Cachectic patients with chronic heart failure show growth hormone resistance. 79th Annual Meeting The Endocrine Society, Minneapolis, 1997, p. 455.
56. Pflaum, C.D., Anker, S.D., Leyva, F., Rauchhaus, M., Coats, A.J.S. & Strasburger, C.J. (1998) Lack of suppression of growth hormone (GH) levels by glucose in patients with cardial cachexia: further evidence for GH resistance. 80th Annual Meeting The Endocrine Society, New Orleans, 1998, p. 163.
57. Rodrigues, E.A., Caruana, M.P., Lahiri, A., Nabarro, J.D.N., Jacobs, H.S. & Raftery, E.B. (1989) Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. British Heart Journal, 62, 185-194.
58. Roelen, C.A.M. (1992) A method for measuring the binding affinity and capacity of the growth hormone binding protein using FPLC to separate bound and free ligand. Journal of Liquid Chromatography, 15 (8), 1259-1275..
59. Rudman, D., Kutner, M.H., Goldsmith, M.A., Kenny, J., Jennings, H. & Bain, R.P. (1980) Further observations on four subgroups of normal variant short stature. Journal of Clinical Endocrinology and Metabolism, 51, 1378-1384.
60. Saccà, L., Cittadini, A. & Fazio, S. (1994) Growth Hormone and the heart. Endocrine Reviews, 15, 555-573.
61. Sahn, D.J., De Maria, A., Kisslo, J. & Weyman, A. (1978) Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 58, 1072-1083.
62. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P. (1989) The effect of treatment with recombinant human Growth Hormone on body composition and metabolism in adult with Growth Hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
63. Schiller, N.B., Shahn, P.M., Crawford, M., De Maria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D. & Schnittger, I. (1989) Recommendation for quantitation of the Left Ventricle by Two-dimensional echocardiography. Journal of the American Society of Echocardiography, 2 (5), 358-367.
64. Shahi, M., Beshyah, S.A., Hackett, D., Sharp, P.S., Johnston, D.G. & Foale, R.A. (1992) Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality, British Heart Journal, 67, 92-96.
65. Sklar, M.M., Kiess, W., Thomas, C.L. & Nissley, S.P. (1989) Developmental expression of the tissue insulin-like growth factor II/mannose 6-phosphate receptor in the rat. Journal Biological Chemistry, 264, 16733-16738.
66. Snyder, D.K., Clemmons, D.R. & Underwood, L.E. (1989) Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. Journal of Clinical Endocrinology and Metabolism, 69, 745-752.
67. Thissen, J.P., Ketelslegers, J.M. & Underwood, L.E. (1994) Nutritional regulation of the Insulin-like growth factors. Endocrine Reviews, 15, 80-101.
68. Thorner, O., Vance, M., Horvath, E. & Kovaacs, K. (1992) The Anterior pituitary. Williams textbook of Endocrinology 8th Edn. pp. 221-310. Saunders Co., Philadelphia.
69. Thuesen, L., Christensen, S.E., Wecke, J., Orskov, H. & Henningen, P. (1988) A hyperkinetic heart in uncomplicated active acromegaly: explanation of hypertension in acromegalic patients? Acta Medica Scandinavica, 223, 337-343..
70. Timsit, J. & Mercadier, J.J. (1992) Effects of chronic growth hormone excess on cardiac contractility and myosin phenotype in the rat. Acta Paediatrica, 383, 32-34.
71. Timsit, J., Riou, B., Bertherat, J., Wisnewsky, C., Kato, N.S., Weisber, A.S., Lubetzki, J., Lecarpentier, Y., Winegrad, S. & Mercadier, J.J. (1990) Effects of chronic Growth Hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. Journal of Clinical Investigation, 86, 507-515.
72. Tucci, M., Nygard, K., Tanswell, B.V., Farber, H.W., Hill, D.J. & Han, V.K.M. (1998) Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. Journal of Endocrinology, 157, 13-24.
73. Unterman, T.G., Vazquez, K.M., Slas, A.J., Martyn, P.A. & Phillips, L.S. (1985) Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment. American Journal of Medicine, 78, 228-234.
74. Valcavi, r., Dieguez, C., Zini, M., Muruais, S., Casanueva, F. & Portioli, I. (1993) Influence of hyperthyroidism on growth hormone secretion. Clinical Endocrinology, 38, 515-522.
75. Valcavi, R., Gaddi, O., Zini, M., Iavicoli, M., Mellino, U. & Portioli, I. (1995) Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. Journal of Clinical Endocrinology and Metabolism, 80, 659-666.
76. Valcavi, R. & Zini, M. (1992) Thyroid hormone and growth hormone and IGF-I secretion. In: Regulation of growth hormone and somatic growth (eds. L.P. De la Cruz), pp. 183-217. Elsevier Science Publisher, New York.
77. Volterrani, M., Desenzani, P., Lorusso, R., d'Aloia, A., Manelli, F. & Giustina, A. (1997) Haemodinamic effects of intravenous growth hormone in congestive heart failure. Lancet, 359, 1067-1068.
78. Yang, R., Bunting, S., Gillett, N., Clark, R. & Jin, H. (1995) Growth hormone improves cardiac performance in experimental heart failure. Circulation, 92, 262-267.